Literature DB >> 8224661

Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis.

F M Giardiello1, S R Hamilton, A J Krush, J A Offerhaus, S V Booker, G M Petersen.   

Abstract

Four patients with nasopharyngeal angiofibroma and familial adenomatous polyposis are reported here. Nasopharyngeal angiofibroma was 25 times more frequent in our patient population with familial adenomatous polyposis than in an age-matched hospital population. The association of these two rare conditions suggests that nasopharyngeal angiofibroma is an extracolonic manifestation of adenomatous polyposis. In addition, somatic mutation of the adenomatous polyposis coli gene, which causes adenomatous polyposis when mutated in the germline, could play a role in the pathogenesis of sporadic nasopharyngeal angiofibroma.

Entities:  

Mesh:

Year:  1993        PMID: 8224661     DOI: 10.1016/0016-5085(93)90164-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

Review 1.  Hereditary Colorectal Cancer: Genetics and Screening.

Authors:  Lodewijk A A Brosens; G Johan A Offerhaus; Francis M Giardiello
Journal:  Surg Clin North Am       Date:  2015-06-16       Impact factor: 2.741

2.  Genetic evidence that juvenile nasopharyngeal angiofibroma is an integral FAP tumour.

Authors:  R Valanzano; M C Curia; G Aceto; S Veschi; L De Lellis; T Catalano; G La Rocca; P Battista; A Cama; F Tonelli; R Mariani-Costantini
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

3.  Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx.

Authors:  Edward B Stelow; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2017-02-28

4.  Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas.

Authors:  S C Abraham; E A Montgomery; F M Giardiello; T T Wu
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  Juvenile nasopharyngeal angiofibroma: no evidence for inheritance or association with familial adenomatous polyposis.

Authors:  Tuomas Klockars; Suvi Renkonen; Ilmo Leivo; Jaana Hagström; Antti A Mäkitie
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

6.  Identification of CTNNB1 mutations, CTNNB1 amplifications, and an Axin2 splice variant in juvenile angiofibromas.

Authors:  Silke Wemmert; Vivienne Willnecker; Philipp Kulas; Stefanie Weber; Cornelia Lerner; Sabrina Berndt; Olaf Wendler; Bernhard Schick
Journal:  Tumour Biol       Date:  2015-11-17

Review 7.  Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update.

Authors:  Hiroyuki Aihara; Nitin Kumar; Christopher C Thompson
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-03       Impact factor: 2.566

8.  [Chromosomal alterations in juvenile angiofibromas].

Authors:  C Brunner; S Urbschat; V Jung; M Praetorius; B Schick; P K Plinkert
Journal:  HNO       Date:  2003-12       Impact factor: 1.284

Review 9.  Extra-intestinal manifestations of familial adenomatous polyposis.

Authors:  Emma J Groen; Annemieke Roos; Friso L Muntinghe; Roelien H Enting; Jakob de Vries; Jan H Kleibeuker; Max J H Witjes; Thera P Links; André P van Beek
Journal:  Ann Surg Oncol       Date:  2008-07-09       Impact factor: 5.344

Review 10.  Review of Pediatric Head and Neck Neoplasms that Raise the Possibility of a Cancer Predisposition Syndrome.

Authors:  Nahir Cortes-Santiago; Kalyani Patel
Journal:  Head Neck Pathol       Date:  2021-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.